High-dose intravenous immunoglobulin (IVIG) adjuvant therapy for cell-mediated pancreas transplant rejection.

TitleHigh-dose intravenous immunoglobulin (IVIG) adjuvant therapy for cell-mediated pancreas transplant rejection.
Publication TypeJournal Article
Year of Publication2013
AuthorsHartono C, Kim J, McDermott J, Seshan SV, Serur D
JournalTransplantation
Volume96
Issue5
Paginatione43-4
Date Published2013 Sep 15
ISSN1534-6080
KeywordsAdult, Graft Rejection, Humans, Immunoglobulins, Intravenous, Male, Pancreas Transplantation, Transplantation, Homologous
DOI10.1097/TP.0b013e3182a04974
Alternate JournalTransplantation
PubMed ID23995870
Related Faculty: 
Surya V. Seshan, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700